GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Earnings per Share (Diluted)

Shire (SHPG) Earnings per Share (Diluted) : $15.75 (TTM As of Sep. 2018)


View and export this data going back to 1998. Start your Free Trial

What is Shire Earnings per Share (Diluted)?

Shire's Earnings per Share (Diluted) for the three months ended in Sep. 2018 was $1.74. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2018 was $15.75.

Shire's EPS (Basic) for the three months ended in Sep. 2018 was $1.77. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2018 was $15.87.

Shire's EPS without NRI for the three months ended in Sep. 2018 was $1.74. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2018 was $15.75.


Shire Earnings per Share (Diluted) Historical Data

The historical data trend for Shire's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire Earnings per Share (Diluted) Chart

Shire Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.53 17.28 6.60 1.26 14.04

Shire Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.80 10.20 1.80 2.01 1.74

Competitive Comparison of Shire's Earnings per Share (Diluted)

For the Biotechnology subindustry, Shire's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shire's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shire's PE Ratio distribution charts can be found below:

* The bar in red indicates where Shire's PE Ratio falls into.



Shire Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Shire's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2017 is calculated as

Diluted Earnings Per Share (A: Dec. 2017 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(4271.5-0)/304.000
=14.05

Shire's Earnings Per Share (Diluted) for the quarter that ended in Sep. 2018 is calculated as

Diluted Earnings Per Share (Q: Sep. 2018 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(537.2-0)/307.033
=1.75

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $15.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Shire  (NAS:SHPG) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Shire Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Shire's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Shire (SHPG) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.
Executives
James H Cavanaugh director 265 HOTHORPE LANE, VILLANOVA PA 19085

Shire (SHPG) Headlines

From GuruFocus

Chris Davis' Top 3 Buys of the 1st Quarter

By James Li James Li 05-14-2018

David Abrams Buys Shire, Boosts Lithia Motors

By Tiziano Frateschi Tiziano Frateschi 11-14-2018